FTH
Faeth Therapeutics, Inc. · Healthcare · Market cap $863.1M
Insiders bought $1.2M net in the last 90 days ·0 sellers, 2 buyers· latest Form 4 filed Jul 1, 2026
Insider Buying
$1.2M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Jul 1, 2026
STEPHENSON BRIAN C
Faeth Therapeutics, Inc. (FTH) has 6 SEC Form 4 filings (27 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 1, 2026.
Inside the rolling window, 2 insiders at Faeth Therapeutics, Inc. reported 8 open-market purchases totaling $1.2M and no open-market sales. The most active filer is Chief Financial Officer STEPHENSON BRIAN C with 7 filings. Insiders have net bought $1.2M over the trailing 6 months. The most recent open-market filing is a purchase of 831 shares by Chief Financial Officer STEPHENSON BRIAN C, dated Jun 29, 2026, worth $19K.
- Industry:Biotechnology
- CEO:Anand Parikh
- Employees:29
- HQ:Rockville, MD, US
- IPO:2021-02-04
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Financial Officer | Purchase | 831 | $19K | Jul 1 | +41.2% | SEC ↗ | |
| Chief Financial Officer | Purchase | 7,803 | $189K | Jul 1 | +41.2% | SEC ↗ | |
| Chief Financial Officer | Purchase | 5,000 | $117K | Jul 1 | +41.2% | SEC ↗ | |
| Chief Financial Officer | Purchase | 9,391 | $245K | Jun 26 | +46.0% | SEC ↗ | |
| Chief Financial Officer | Purchase | 6,250 | $156K | Jun 26 | — | SEC ↗ | |
STEPHENSON BRIAN CFirst filing | Chief Financial Officer | Purchase | 8,183 | $181K | Jun 24 | — | SEC ↗ |
STEPHENSON BRIAN CFirst filing | Chief Financial Officer | Purchase | 9,230 | $225K | Jun 24 | — | SEC ↗ |
Parikh Anand KiranFirst filing | President and CEO | Purchase | 2,806 | $55K | Jun 24 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does FTH have?
Faeth Therapeutics, Inc. (FTH) has 6 SEC Form 4 filings (27 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Jul 1, 2026.
When was the most recent SEC Form 4 filing for FTH?
The most recent Form 4 filing for FTH on Tracefour is dated Jul 1, 2026.
Who is the most active insider at FTH?
The most active SEC Form 4 filer at FTH in the rolling window is Chief Financial Officer STEPHENSON BRIAN C, with 7 filings.
What is the net insider flow at FTH over the last 6 months?
Over the trailing 180 days, insiders at FTH have net bought $1.2M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at FTH in the current window?
Inside the rolling window, insiders at FTH bought $1.2M and sold $0 based on SEC Form 4 filings.
Can I get alerts for FTH insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Faeth Therapeutics, Inc. (FTH). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Faeth Therapeutics, Inc. is in the Healthcare sector.